Print

LeMaitre Vascular, Inc. Graft Recall Gets FDA's Highest Warning  
7/25/2013 7:56:36 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The FDA puts its highest-risk label on a recall of LeMaitre Vascular's Albograft vascular graft. The FDA put its highest-risk Class I label on a recall issued by LeMaitre Vascular (NSDQ:LMAT) over leakage concerns for the Albograft vascular grafts. The affected devices, manufactured in April 2011 and distributed through June 2013, were only distributed in Pennsylvania, according to the FDA notice.

Help employers find you! Check out all the jobs and post your resume.

//-->